Peptide Initiative

Peptides · Peptide comparison

CJC-1295 (No DAC) vs Sermorelin

A modified growth hormone-releasing hormone that boosts your body's natural GH pulses for better recovery, deeper sleep, and improved body composition [13] [17].

The original growth hormone booster that works with your body's natural rhythm—it tells your pituitary gland to release more GH instead of replacing it, keeping your hormonal feedback system healthy and balanced.

  • Growth Hormone
  • Growth Hormone

At a glance

Quick comparison

Dose rangeCJC-1295 (No DAC)100–100 mcgSermorelin200–300 mcg
FrequencyCJC-1295 (No DAC)Once dailySermorelinOnce daily
AdministrationCJC-1295 (No DAC)Subcutaneous injectionSermorelinSubcutaneous injection
Cycle lengthCJC-1295 (No DAC)8-12 weeksSermorelin12+ weeks
Onset speedCJC-1295 (No DAC)Moderate (1-2 weeks)SermorelinModerate (1-2 weeks)
Evidence levelCJC-1295 (No DAC)Moderate human trials (Phase 1-2)SermorelinModerate human trials (Phase 1-2)

Efficacy

Benefit ratings

GH Stimulation

CJC-1295 (No DAC)88%
SermorelinNo recorded rating

Sleep Quality

CJC-1295 (No DAC)92%
Sermorelin88%

Recovery Support

CJC-1295 (No DAC)85%
SermorelinNo recorded rating

GH Optimization

CJC-1295 (No DAC)No recorded rating
Sermorelin92%

Body Composition

CJC-1295 (No DAC)No recorded rating
Sermorelin85%

Technical data

Compound specifications

CJC-1295 (No DAC)

Molecular formula
C152H252N44O42
Molecular weight
3367.9 g/mol
Half-life
30 minutes to 2 hours
Bioavailability
~100% (subcutaneous)
CAS number
863288-34-0

Sermorelin

Molecular formula
C149H246N44O42S
Molecular weight
3357.9 g/mol
Half-life
10-20 minutes
Bioavailability
High when injected subcutaneously; degraded orally
CAS number
86168-78-7

Protocols

Dosing compared

CJC-1295 (No DAC)

Subcutaneous

  • 100 mcgOnce daily, 30 minutes before bed · 2-4 weeksA common starting dose used in research practice. Because the no-DAC form is short-acting (about 30 minute half-life), it is injected on an empty stomach for the best growth-hormone pulse. [14][15]
  • 100 mcg per dose1-2 times daily · 8-12 weeksThe typical maintenance dose used in practice, often given before bed and/or after fasted exercise. Frequently paired with a GH-releasing peptide.
  • 100 mcg per dose2-3 times daily · 8-12 weeksA higher-frequency plan used by experienced users to mimic natural GH pulses across the day, each dose taken fasted.

Sermorelin

Subcutaneous

  • 100-200 mcgOnce daily at bedtime · 4-6 weeksCommunity-practice dose, not one studied in adults. The adult trials used 0.5–1 mg twice daily [1] or 2 mg nightly [3]; the pediatric label dose was 30 mcg/kg at bedtime [6].
  • 200-300 mcgOnce daily at bedtime · 3-6 monthsCommunity-practice dose. Twice-daily 1 mg (not 200–300 mcg) is the dose that restored GH and IGF-1 in older men [1].

Applications

Best suited for

CJC-1295 (No DAC)

Natural Growth Hormone Optimization
Perfect for those wanting to boost their body's own GH production rather than using synthetic growth hormone. Mimics the natural pulsatile release pattern your pituitary uses [2].
Workout Recovery and Muscle Building
Athletes and fitness enthusiasts use it to accelerate recovery between training sessions, support lean muscle development, and reduce body fat over time [17] [18].
Sleep Quality Enhancement
Because GH is naturally released during deep sleep, many users report dramatically improved sleep quality with more vivid dreams and feeling more refreshed upon waking [12] [13].
Anti-Aging and Vitality
As GH levels decline with age, CJC-1295 helps restore more youthful hormone patterns, potentially improving skin quality, energy levels, and overall well-being [16] [17] [20].
Synergistic Peptide Stacking
Designed to work hand-in-hand with GHRPs like Ipamorelin. When combined, these peptides amplify each other's effects for significantly greater GH release than either alone [9].

Sermorelin

Adults Experiencing Age-Related GH Decline
After age 30, your growth hormone production naturally declines about 14% per decade. [9] Sermorelin helps restore more youthful GH levels by stimulating your own pituitary rather than shutting it down with external hormones. [1][13] It's like giving your hormone system a gentle nudge back to where it used to be.
Body Composition Optimizers
Evidence for body composition is limited. A GHRH analog increased lean mass in older men but not women, with no change in fat [2]; 6 weeks of nightly sermorelin changed neither muscle nor fat [3]. Larger, longer studies are lacking. [8]
Sleep Quality Seekers
Growth hormone is intimately tied to deep, restorative sleep. [10] By enhancing your natural nighttime GH pulses, sermorelin often improves sleep quality as a welcome side effect. [8] Many users report falling asleep faster and waking more refreshed.
Those Wanting a Safer Alternative to HGH
Direct HGH injections bypass your body's feedback system and can suppress your own production. [13] Sermorelin works differently—it asks your pituitary to make more GH naturally. This preserves your body's regulatory mechanisms and carries a lower risk of side effects. [8]

Safety profile

Side effects

CJC-1295 (No DAC)

Common

  • Injection site reactions
  • Flushing or warmth
  • Water retention
  • Increased appetite

Uncommon

  • Tingling or numbness
  • Headache

Serious

  • Allergic reaction

Sermorelin

Common

  • Injection site reactions
  • Facial flushing

Uncommon

  • Headache
  • Sleepiness or drowsiness
  • Nausea
  • Hyperactivity or difficulty sleeping

Serious

  • Severe allergic reaction

Research status

Safety & evidence

CJC-1295 (No DAC)

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
CJC-1295 without DAC itself has not been evaluated in controlled human clinical trials; expectations about its safety are extrapolated from studies of related GHRH analogs. The most common side effects are mild and include injection site reactions and temporary flushing [19]. Because it stimulates natural GH release rather than providing exogenous GH, it maintains the body's feedback mechanisms [2].

Contraindications

  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Pituitary tumors or disorders
  • Hypersensitivity to GHRH analogs
  • Diabetic retinopathy

Sermorelin

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Not currently FDA approved. GEREF (sermorelin) was approved in 1997 for growth failure in children with GH deficiency; EMD Serono discontinued it in 2008 and FDA withdrew the approvals at its request in 2009, not for safety or effectiveness reasons. Sermorelin sold today is compounded, not an FDA-approved product.
Safety overview
Sermorelin works through the body's own GH feedback, which limits excessive hormone levels. [8][13] On the GEREF label, the most common reaction to repeated injections was a local reaction (about 1 in 6 patients); headache, flushing, dizziness, hyperactivity and somnolence each occurred in under 1%, and many patients developed anti-GRF antibodies. [16] Facial flushing and injection-site pain were the most commonly reported events in the pediatric studies. [6] GEREF was FDA-approved in 1997 for children with GH deficiency. [7]

Contraindications

  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Known allergy to sermorelin or any peptide components
  • Pituitary tumors or other pituitary disorders
  • Diabetic retinopathy

Decision guide

Which is right for you?

CJC-1295 (No DAC)

Choose CJC-1295 (No DAC) if…

  • Increasing natural growth hormone levels
  • Building lean muscle mass
  • Improving sleep quality
  • Enhancing workout recovery

Sermorelin

Choose Sermorelin if…

  • Anti-aging and vitality
  • Body composition improvement
  • Sleep quality enhancement
  • Exercise recovery